Form 10-Q · Quarterly report
Elevance Health 10-Q, filed Oct 21, 2026
- Filed
- CIK
- 0001156039
- Accession no.
- 0001156039-26-000071
Summary
Elevance Health served approximately 44.9 million medical members as of September 30, 2026, and said Medicaid and individual ACA morbidity trends are driving elevated medical costs. Its CarelonRx business entered a new five-year agreement with CVS Health's CaremarkPCS Health beginning January 1, 2027, and the company outlined regulatory changes from the One Big Beautiful Bill Act and recent pharmacy benefit manager reforms.
Key points
- Elevance Health operates four reportable segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other.
- CarelonRx entered a new five-year agreement with CVS Health's CaremarkPCS Health, continuing the relationship from January 1, 2027 through December 31, 2031.
- The One Big Beautiful Bill Act, signed July 4, 2025, includes Medicaid reverification, work or community engagement requirements, changes to state directed payments and provider taxes, and a new Rural Health Transformation program.
- In February 2026, Congress passed the Consolidated Appropriations Act of 2026, which includes pharmacy benefit manager reforms requiring rebates and fees to be remitted to commercial plan sponsors and delinks PBM compensation in Medicare Part D by 2028.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview Elevance Health is a health company with the purpose of improving the health of humanity. We are one of the largest health insurers in the United States in terms of medical membership, serving approximately 44.9 million medical members through our affiliated health plans as of September 30, 2026. We are an independent licensee of the Blue Cross and Blue Shield Association (“BCBSA”), an association of independent health benefit plans. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.